Quick Takeaways
- InCube Labs, L.L.C. filed SCHEDULE 13D/A for RANI THERAPEUTICS HOLDINGS, INC. Class A Common Stock, par value $0.0001 per share (RANI).
- Disclosed ownership: 22%.
- Date of event: 23 Oct 2025.
InCube Labs, L.L.C. - 23 Oct 2025 SCHEDULE 13D/A Report for RANI THERAPEUTICS HOLDINGS, INC. Class A Common Stock, par value $0.0001 per share (RANI)
- Filing Manager
- InCube Labs, L.L.C.
- Reporting Manager
- MIR A IMRAN
- Symbol
- RANI
- Shares outstanding
- 122,595,258 shares
- Disclosed Ownership
- 27,093,552 shares
- Ownership
- 22%
- Form type
- SCHEDULE 13D/A
- Filing time
- 27 Oct 2025, 21:49:06 UTC
- Date of event
- 23 Oct 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"InCube Labs, L.L.C. disclosed 22% ownership in RANI THERAPEUTICS HOLDINGS, INC. Class A Common Stock, par value $0.0001 per share (RANI) on 23 Oct 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 27 Oct 2025, 21:49.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| InCube Labs, L.L.C. | 19% | 22,424,788 | 22,424,788 | 0 | /s/ Mir Imran | Mir Imran, Managing Member | 0001873082 |
| MIR A IMRAN | 22% | 27,093,552 | 27,093,552 | 0 | /s/ Mir Imran | Mir Imran | 0001031686 |
| InCube Ventures II, LP | 0.3% | 301,710 | 301,710 | 0 | /s/ Mir Imran | Mir Imran, General Partner | |
| Rani Investment Corp. | 0% | 7,694 | 7,694 | 0 | /s/ Mir Imran | Mir Imran, General Partner |